Aquestive Therapeutics AQST
NASDAQ AQST
$3.55 +0.01 (+0.28%)
As of: Nov 10, 2026 · 3:45 PM EST

Aquestive Therapeutics (AQST) Share-based Compensation (2018 - 2026)

Updated

Aquestive Therapeutics (AQST) reported Share-based Compensation of $2.13 million for Q3 2026, down 23.4% from $2.78 million a year earlier and down 26.6% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Share-based Compensation (2018 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Aquestive Therapeutics' Share-based Compensation came in at $8.72 million, up 0.7% year-over-year; for FY2025, it was $7.62 million, up 7.4% from FY2024.

  • Share-based Compensation has a five-year compound annual growth rate of 3.0% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $7.1 million in FY2024 (+164.0%), $2.69 million in FY2023 (-38.6%), $4.38 million in FY2022 (-35.8%) and $6.82 million in FY2021 (+3.6%).
  • Five-year quarterly Share-based Compensation spans a low of $344,000 in Q1 2023 and a high of $2.9 million in Q2 2026.
  • Year over year, Share-based Compensation gained in six of the last eight quarters, with growth averaging 36.0%.
  • The high point for year-over-year Share-based Compensation in five years was Q1 2024 (growth of 359.3%); the low point was Q3 2022 (a decline of 71.8%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $2.9 million (Q2 2026), $2.32 million (Q1 2026) and $1.38 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 357.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 160.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 234.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 362.00 Mn
10 Aquestive Therapeutics 445.70 Mn 24.96 Mn 3.95 Mn 2.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.13 Mn
Jun 30, 2026 2.90 Mn
Mar 31, 2026 2.32 Mn
Dec 31, 2025 1.38 Mn
Sep 30, 2025 2.78 Mn
Jun 30, 2025 1.88 Mn
Mar 31, 2025 1.59 Mn
Dec 31, 2024 2.40 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 1.54 Mn
Mar 31, 2024 1.58 Mn
Dec 31, 2023 940,000.00
Sep 30, 2023 774,000.00
Jun 30, 2023 631,000.00
Mar 31, 2023 344,000.00
Dec 31, 2022 714,000.00
Sep 30, 2022 535,000.00
Jun 30, 2022 2.22 Mn
Mar 31, 2022 913,000.00
Dec 31, 2021 1.69 Mn
API Access

Aquestive Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AQST&period=max&api_key=YOUR_API_KEY